The Sim Cafe~

From Toy Maker To Lifesaver: How Laerdal Scaled CPR, Simulation, And Global Health Impact

• Deb Tauber • Season 3 • Episode 113

Share episode

Send us a text

A near-drowning in the Norwegian fjords set a family on a path that would change how the world learns to save lives. We sit down with Jon Laerdal, Chief Product Officer at Laerdal Medical, to explore the unlikely journey from toy design to Resusci Anne, from classroom CPR to on‑the‑unit practice that measurably improves survival.

Jon pulls back the curtain on how evidence and guidelines have shaped Laerdal’s resuscitation portfolio and why RQI—Resuscitation Quality Improvement—now embedded in 3,000 U.S. hospitals, is redefining competency with low‑dose, high‑frequency training. We dive into the Safer Births program in Tanzania, co‑created with the American Academy of Pediatrics and Jhpiego, where frequent, team‑based simulations on the ward correlate with dramatic reductions in newborn and maternal deaths. The thread through it all is a simple, rigorous idea: put practice where care happens, make it frequent, and let data guide improvement.

We also talk about the tech landscape without the hype. VR and mixed reality bring decision‑making into virtual and blended spaces, while AI lightens scenario design and powers more responsive debriefs. But the payoff comes when these tools join a circular learning model—reading, skills, simulation, team training, and clinical practice—connected by actionable insights. That is where simulation evolves from a one‑off event to a quality improvement engine that exposes latent safety threats and closes the gap between training and therapy.

If more than half of global deaths stem from time‑critical emergencies, preparing responders everywhere is not optional; it’s urgent. Jon shares Laerdal’s goal to help save one million more lives by 2030 and offers concrete steps educators and leaders can take to build cultures of practice that stick. Subscribe, share with a colleague who champions simulation, and leave a review with one question you want us to ask our next guest.

Innovative SimSolutions.
Your turnkey solution provider for medical simulation programs, sim centers & faculty design.

Disclaimer/ SIM vs/ Intro:

The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of anyone at Innovative Sim Solutions or our sponsors. Thanks to SIMVS for sponsoring this week's episode. The new SIMVS IV Infusion Pump Simulator is the first to market in this critical learning area, with great realism and advanced features like simulation med orders, gamified med errors, and more. SIMVS IV significantly reduces the burden for training proper IV administration when compared to refurbished pumps. SimVS IV helps students develop the confidence needed in a safe environment before facing the challenges of modern healthcare. To learn more, visit www.simvs.com. Welcome to The Sim Cafe, a podcast produced by the team at Innovative Sim Solutions, edited by Shelly Houser. Join our host, Deb Tauber, and co-host Jerrod Jeffries as they sit down with subject matter experts from across the globe to reimagine clinical education and the use of simulation. So pour yourself a cup of relaxation, sit back, tune in, and learn something new from The Sim Cafe.

Deb Tauber:

Welcome to The Sim Cafe podcast, where we bring together leaders, educators, and innovators shaping the world of healthcare simulation. I'm your host, Deb Tauber, and co-host Jerrod Jeffries, and today we're honored to welcome a truly visionary guest, Jon Laerdal, Chief Product Officer of Laerdal Medical. For more than 75 years, Laerdal has been dedicated to the mission of saving lives, pioneering innovations that have transformed healthcare, training, and patient safety across the globe. Welcome and thank you, Jon, for being a guest today.

Jon Laerdal:

Thank you. I'm glad to be here.

Jerrod Jeffries:

That's uh a lot to start off with, but I think that the company Laerdal needs very little to any introduction, but I'll I'll mention a few words before we we dig in. Because of course, we want to hear more about you, your role and your history within the company, but also what you're doing today. And I think that there's there's two parts of Laerdal as a company, with one, of course, being Global Evil's leaders in both the healthcare simulation side and it's also resuscitation. But I want to first focus on the company's mission of helping save lives and how that's potentially evolved throughout the years. Can you take us through the long journey down a you know a visual museum here, starting from the early beginning to where we are today?

Jon Laerdal:

Sure. The company was founded in uh 1940 by my grandfather. And the focus at the time was uh as a publishing company, publishing books, but also soon after started developing toys for children. So the mission back then wasn't helping save lives, but it was uh creating children's joy. And a long story short, my grandfather and his colleagues they made very successful, a big range of different uh toys. And one was an Annie mannequin, but it was an Annie doll. And he had a traumatic episode in in the 50s, my grandfather, where my father had a near-drowning accident. So he was just floating in the in the fjords of Norway, uh, kept floating by an air pocket in his raincoat. So this was before the birth of CPR in 1960, and my grandfather did what he thought was best to do, and he got uh air out of the lungs of my father, who was only two at the time, and he successfully uh brought him back to life. And uh this was uh both a traumatic experience, as you can imagine, but also a very inspirational moment for the founder. So after this episode, he dedicated himself with his colleagues to help train and prepare other lifesavers to do what he had to do. And he got uh in contact with um various healthcare leaders, including uh Dr. Peter Safar, sometimes referred to as the father of CPR. And together they code created the first Annie mannequin, which we sometimes refer to as the first patient simulator. So that's really uh a bit in short how the company evolved from creating children's joy through building up a know-how on creating products for children, but also plastics and going from an ani doll to a life-sized Annie simulator, which has helped uh train a lot of people. Uh AHA has estimated about 500 million in uh getting trained and prepared for for acting in the moment of a cardiac arrest patient. And they also estimate that it's uh has helped uh save two and a half million people. That's some of the of the history we have.

Jerrod Jeffries:

That's pretty incredible. And in AHA being the American Heart Association.

Jon Laerdal:

Yes, yes.

Jerrod Jeffries:

Yeah, so so you have statistics that's showing that just yeah, it's it's hard to even fathom the amount of lives that due to a extremely unfortunate incident that that turned out to be okay, but that one situation then led to the survival and the ability to save so many lives decades later.

Jon Laerdal:

Yeah, and of course, we are playing a small part into that. My grandfather chose the symbol of the Good Samaritan. That was the ex librus of his uh father-in-law, who was a surgeon, and he chose that because it reflected really the focus on the helper, which is also why we have the slogan of helping save lives. So, of course, Laerdol as a company and our products doesn't save lives, but we help prepare uh and equip lifesavers to act in the in the moment. So that's of course how we have helped. But we're quite uh proud about having had that opportunity to to help so many lifesavers get uh get trained and prepared via big organizations like American Heart Association and many, many other organizations who actually are, of course, doing the real work and getting people trained and the lifesavers to act in the moment.

Deb Tauber:

Thank you. That's the first time I've heard that story, and I truly got the chills hearing it. It's an amazing, amazing story to start out making creating joy for for children, and then to suddenly be swept into the reality of hey, we need to do something different here. Your father had to be just so overwhelmed with emotions of thinking that your your father wouldn't be okay and how resuscitation at that time wasn't something that was anything that was even thought of, I'm sure.

Jerrod Jeffries:

Yeah, and I think times like those, that's when some people think you're crazy, right? You're you're pushing on someone's chest and you're thinking, okay, what do you what are you doing? And it's always, I think it's was it the Cassandra when you when you think you're when you think you're right, but you're too early to be right. And then it's like, I mean, obviously that you see the science behind resuscitation now and fast forward a couple decades or even go back a couple decades, and people think, okay, well, healthcare simulation, a farce, it's not really something. And then now we're seeing more and more data emerge. And of course, Laerdol's taking, taking the ring there of pushing innovation forward and helping partners, of course, to your term, Jon, helping them save lives.

Deb Tauber:

So now we'll get more into simulation, but first tell us about the other side of Laerdal and how the company's focusing on the resuscitation market.

Jon Laerdal:

Yeah, I did just uh refer to how we got into it with that uh experience of the founder. And we then launched the first Resourcean in 1960, which is also considered to be the birth of CPR as a method. And we've been very closely following uh research and evidence, in particular the the guidelines from Ilcor and HA and ERC and other restation council, and always tried to to um to meet the evolving needs as per the guidelines throughout the decades. So you can really, if you were to go back or go into a museum, you can sort of see the guidelines and what they said was the need at the time. And then we've responded with the story of Resocian is really that it has evolved for the needs of the guidelines. Today we we have a big range uh of restation products, both in therapy and in training. We support a range of uh segments from the lay people, as maybe 70 to 80 percent of cardiac arrest happen in the home. So we need to help people where they are. And that's why we've always been very committed to helping train lay people in the community via voluntary organizations. And there's of course uh lots of healthcare students getting trained and uh and also the healthcare professionals. And we have everything from suction and airway products in the therapy range from newborns to to geriatric mannequins and simulators to help really train relevant scenarios. And then we also we've worked closely. We have an we have an alliance with the American Heart Association and establish a joint venture in uh 2018. And that was really to scale up and focus on a solution we're very excited about, and that is now in 3,000 hospitals out of 5,000 in the US, which is RQI, and it's all about democratizing really the access to CPR training so that you don't only have to go to a course, which might not be practical, but you can actually get training on the job little and often, so-called low dose high frequency. So we have uh today um a portfolio that's evolved and responded to the various needs that we see from evidence, and we have instructor-led solutions and we have this self-directed solution where we have now more than four million people in in uh predominantly the US that are taking their CPR training and certification via the RQI system with American Heart Association.

Jerrod Jeffries:

Thank you. Pretty impressive. I mean, it's it it is incredible though to see how one, you listen to users, but two, you also adapt to market, I don't say conditions, but the way the market needs and feels based off evidence. And I mean RQI resuscitation quality improvement is simply a testament to this. And then of and then I think that, and correct me if I'm wrong here, but I also heard some people talking about this Laerdol Global Health. Could you give us a little bit of information on on that piece too? Because I know that's separate, or is that the same, or how does that work with with Laerdol Medical?

Jon Laerdal:

So Laerdol Global Health is a not-for-profit company. It was set up to help train birth attendants to respond to um the most serious situations on the day of birth, so both for the mother and the baby. So every day there's about 6,000 babies dying every day, and about 800 mothers dying every day. And most of these are preventable, and most of these are happening in lower source settings. So via our amazing network, including JopaiGo and American Academy of Pediatrics, we were exposed to seeing some enormous opportunities to help make a difference. So we've been working with American Academy of Pediatrics and JopaiGo and many other organizations to then understand the needs for these birth attendants and scale then really effectful programs. So, yeah, that's that's the story of LGH. And today it's been bringing forth uh something I think is quite uh exciting within the simulation space, a program called Safer Birds. And it's really a combination of what was developed both with AP and Jabigo, bringing helping babies breathe and uh helping mothers survive together. And a bit similar to the RQI story I was alluding to earlier. It's all about putting a simulation training system into on the job. You put basically available and scalable and easy to use and uh low cost, highly evidence-based. You put that exactly where people are working. So to me, this is one of the most exciting developments and interesting developments that are happening now, largely in Tanzania. I was actually there this summer with my family and I got to see it personally. It was amazing. So you have in the simulation space, people are of course very busy, they're often clinical and barely have time. And the same applies to very busy healthcare providers in in at this hospital in in Tanzania and Haydn. But then again, they still manage to carve out and they train two times a week for their skills training, and every second week simulation training. And I find that extremely interesting. And they train because they see and experience that there's more babies and mothers surviving. So you get this flywheel effect. And to me, that is almost like seeing the vision for what I think simulation should be in uh in the high resource settings. That you can you train on the job little and often, and you only train on what's really relevant, and then you're applying and bridging that gap from training to therapy. And then we can like RQY, we can see how many and where do they train and when they go from A to B by data-driven feedback. So that's some of the that was a lot. Sorry, but that was a lot. You you brought me into all of that now. I love it with asking on the global health. So that's some of the context for that company and and some of the programs we've helped uh co-create with AAP and Japaigo and other partners.

Jerrod Jeffries:

And it's wonderful to see that Laerdal has its hands in so many different areas to rise or lift up health equality in the different areas globally. I mean, it's it because I think you know, most people probably who hear or know of Laerdal Medical, they think of the the US or maybe Australia, UK, parts of Europe. And it's great to see that not only is the foundational arm, but also that of the the global health, which is I think it was sub-Saharan Africa or different parts of Africa you were mentioning. So and I'm sure, I'm sure beyond. But I I do want to shift gears a little and over to the simulation side. And my first question, and I don't know if you can hear this, but is it true? Uh I think I can hear it now. And this Michael Jackson song, Smooth Criminal, is Annie Are You Okay? Does that have reference to a Laerdal Annie mannequin?

Jon Laerdal:

That is indeed true. So um, we didn't know that before some years ago. And uh I was a product manager of uh Resociana at the time and found this just incredible. So yeah, Michael Jackson uh had gone to a CPR. I don't know if he actually went to a CPR training class, but he was exposed to that. And when they're following the protocol and going, Annie Annie, are you okay? Are you okay? And he he thought that sounded so catchy that he ended up uh putting that into I've forgotten how many times it's mentioned in that smooth criminal, but it's a lot of times. Yeah, it's quite mind-boggling.

Jerrod Jeffries:

No, but it I mean it's it's probably the most I mean now okay, now Siri might have outdone it, but or Alexa, Siri or Alexa, but it probably was the most used name for a good while.

Jon Laerdal:

That's true. You mean Annie? Yeah, yeah. Yeah, yeah. There was Princess Annie in the in the UK, and of course it was a name that worked worked both in Norway and internationally. So there was some reasons like that that was behind picking it. Yeah, and Michael Jackson seeing it, who knows how many fans.

Deb Tauber:

So yeah, yeah.

Jerrod Jeffries:

Uh but you know, that's of course, that's from the historical standpoint. But now I wanna I want to look into the future here as well. And so as chief product officer, this now we're switching hats again. I want to hear your thoughts with the the emergence of all this new technology. And you know, I don't I don't think throwing technology at any one problem, you know, is necessarily ever the solution. But as we see this uh AI, VR, AR, XR, whatever you want to call it, and how learning shapes education, how do you see these types of innovations really transforming the simulation landscape over the coming years? And that can be it will say three to five years.

Jon Laerdal:

That's a very good question. And of course, we can all speculate and we can follow what we see. So for us, it's um it's very important to keep learning and uh do something and learn hands-on. So we have various activities ongoing when it comes to VR and uh mixed reality. So we made some products with partners such as uh Walter Klober and National League of Nursing. We're embedding in the VR clinicals case what students need to be exposed to for clinical placement, but in a virtual space. So that's an example of taking VR and combining it also with AI so you can have a conversation uh within that space and be exposed to a busy word where you need to sort of triage between patients and really work on your decision making and judgment skills. That's one example. We have mixed reality, where we show that uh last year's IMSH uh for use with the prompt and the Mama An patient simulator. And now we're working to make that available also for other simulators, and we'll show plan to show some of that at the upcoming ISH. We believe in this uh method of circle of learning, so you can acquire some knowledge and you can get skills training, and you can have in virtual simulation training be exposed to um judgment and decision-making skills, which of course can be 2D with screen-based or VR or MR. And now there is, of course, an amazing digital revolution, and we're trying to make sure that we're also paying attention in class for that. And there is a convergence now of these technologies that is uh quite uh mind-boggling. So you asked about VR, MR, but also data and AI, I believe. Correct. And and there was uh there's a saying about digital can can help do better things, but uh can also do things better. So I think the existing things can clearly be much better, much better and much more enhanced, and and various elements can be more automated. For example, going from VR and you you automate more the conversation. That's one example. Or if you can have AI in a scenario creation tool, so that there's less steps, there's less manual work, and there can be more type of AI enhancing and automating features, not only to automate, but also to make it even better. So there's various things that we're trying to follow. I have noticed that uh in the last couple of IMSH conferences that uh the VR and MR times has been, I believe, about a third almost of the exhibition floor. And it's interesting to follow how people are trying to see what are the biggest needs that can scale. So, again, we like others are trying to see how we can best help with educational tools using those technologies and those learning modalities. And for Laredol, it's really about trying to have this circular learning approach where it's really holistically thought through so that there is different modes of learning from reading a book to a lecture to a skills training to again going into a virtual simulation or skills training environment to then applying that in the Teams and then applying it in clinical, and then you continuously go around. So we're trying to view it from that angle, that it's not an isolated or a sided approach, but we're trying to think quite holistically. And at the center of such a circular learning, you would find data and actionable insights. So the more you can catch the data from the various modes, but also look at that more holistically, we believe there's a lot of value that could be um brought forward for people within education and in um and in healthcare.

Jerrod Jeffries:

I like that. I think it's a more holistic or micro macro way of looking at technology than throwing saying, oh, like the new meta glasses are are gonna, you know, gonna change the game and or throw in Chat GPT and everything's gonna be. I like that data sits in the middle of it. And yeah, I I think we should also probably link that circle of learning in in the show notes for for our listeners. But it's yeah, it's it's just holistic instead of just being fragment fragmented, it's it's a lot more of a larger approach.

Deb Tauber:

Now you alluded a little bit to this, but Laerdol's formed powerful collaborations with universities, NGOs, and global health organizations. Can you share an example of a partnership that's made a meaningful difference in saving lives worldwide? What would you put your put your finger on that one?

Jon Laerdal:

Then I'd like to go back to to Tanzania from this summer. I was there with my family and got to try it hands-on and see the CEO of the hospital taking this uh on-the-job training there and then. So when you have that learning system placed in the clinical space and uh people are intrinsically motivated to train little and often, I think that is incredible to see. And I think that's what we should try and bring out and bring forward in the simulation community worldwide. So that program was co-created with many partners, including uh Jupaigo and American Academy of Pediatrics. It's also been funded by the World Bank, an armor of the World Bank called the Global Financing Facility, where this was one out of many, many hundred different projects that were competing for funding. And it came to the final round and has got uh substantial funding, more than 10 million US dollars to scale in Tanzania. So, what is uh more interesting is that, uh and more important is that not only is this uh a low job, dose, high frequency type training in the work setting, but it's uh it's an evidence-based simulation program. But I think there's a lot of learning to be taking because this is not about something that happens in lower source settings. I think this is extremely uh valuable to learn from. So, what has been proven with more than 100 research papers in the last 15 years and the biggest newborn prestation research program ever, including more than 300,000 birds. Long story short is that when you train people in a course, you could measure some impact, but there wasn't really a translation to clinical performance. And what they found and proven in uh all these research papers is that when you train little and often embedded into a quality improvement culture, it really changes and has an impact. And they found that for babies who many die from birth asphyxia, there was up to a half, uh 50% reduction in uh in death for the for the newborns after people have been doing this low dose high frequency training. And what uh surprised the researcher even more was that uh there was up to uh 70%, seven zero reduction in mothers dying. So, what I think is just unbelievable, and that we see and learn from these healthcare researchers and healthcare providers in uh in Tanzania is that you can track how often they do the team-based simulation. And what they find is that when they're in the team-based simulations, they realize they want to go back individually and they take their own sort of initiative to do go back and do skills training. So, because the skills training systems is just available and it's it's not uh you don't need an instructor or a course or go and find it, it's just there as a self-training station. You can see the growth of the amount of training and you can see the performance. And again, that translates and bridges the gap from training to therapy. So that's a lot of the vision and I think the value creation that we see that when you have data collecting products and when you can have data collecting performance, and you send that real time to the healthcare provider or the team, but also use that for systematic quality improvement within the system, you really get an amazing flywheel. And so, for people who want to learn more about that, I would just uh recommend to Google Safe for Birds and you can go there. And there are some really great presentations also by Professor Heger Afstall that summarizes this. Uh and they also really systematically use this uh circular learning approach to to really drive that quality improvement initiative.

Deb Tauber:

Excellent. So I'm a little curious here. So you go on vacation to Tanzania with your family, and so instead of saying, okay, okay, folks, we're gonna go on a safari, you say we're gonna go visit a hospital. Is it is that what your vacation is?

Jon Laerdal:

That was a good question. Yeah. Um it was actually my my father, who is the chairman of the company, and my mother have been celebrating the golden anniversary. And so this was a special bucket list uh kind of imitation. And myself with my wife and kids and my sisters and their families were invited. And we had two, three days of safari, and then we we went to this hospital, and especially a Torah. My father has been together with uh my sister working very closely with this for for about 15 years. I've only seen this the hospital and pictures of it on slides, and so it was quite mind-boggling to be there. And again, when you're there, because you can read about these things when you're there and you hear and you feel how the leaders and also the birth attendants are talking about why they care and why they train. That was to me, it's hard to articulate the takeaway there, but it was something I think really special where if you can make people train little and often because they want to and because they can see and feel the direct life saving, I think you can't you can't get anything better. So I'm really wondering about how do we capitalize on those learnings and how do we make great products into that and really scale that into uh healthcare worldwide.

Deb Tauber:

I love it.

Jerrod Jeffries:

I won't ask you where your next vacation is going to be, Jon, but uh I'm sure it's probably another hospital somewhere.

Jon Laerdal:

Stavanger hospital, yeah.

Jerrod Jeffries:

I want to kind of wrap this up sooner than later, but I do want to ask uh going back to the simulation side, is one what excites you the most, but also what message do you want to really leave with the simulationists and the educators around the world?

Jon Laerdal:

I think what excites me the most is a combination of a couple of things. It's really capitalizing on what technology now enables. That is absolutely mind-boggling. And I think putting that in context of some of the things we've learned is really the great cocktail we can uh we can come up with. So if we can get people to train little and often and really um have lower cost and higher impact simulation systems, both for instructor-led but also self-training. And what excites me is really trying to bridge that gap between training and therapy that we touched on. So to make that happen in not only the day of birth setting, but to make it happen within any time critical emergencies. And to train people in pre-service and in-service, I think is uh is the most exciting opportunity. More than 30 million people die every year. That's half of the population that dies every year. More than half die from time critical emergencies. And we've set the goal to help save one million more lives by 2030. And that Safe for Birds program alone, if scaled well globally, could help save 200,000 more lives. So there are examples like this where we know from evidence-based, if you scale it up, there's an enormous potential to help save more lives. So I think to be really great at technology and business model innovation and create better and better products that capitalizes on the technologies and drive for impact and scalability. And lastly, I think also to move simulation to be, and this I know has been a talk in the community for a long, long time. And I think there's still a lot of more untapped opportunity and value there, but to go more from training into more healthcare quality improvement and use simulation for, and there's different terms for this, translational simulation or transformative, but to really apply it to to test and to embed and to improve healthcare, everything from the more traditional training teams and individual skills, but more going and just focusing on the system and find those latent safety threats. That I think is extremely exciting that simulation can have an enormous impact to find, uncover, and reduce systematically uh safety threats to patients in healthcare. Was there another question in there?

Jerrod Jeffries:

No, that was again a good, pretty solid answer. I like that.

Deb Tauber:

Yeah, we are so grateful to have had you today. Thank you so much. Now, in closing, again, I'm gonna ask you what does it feel like to be Jon Laerdol? And how would you like to be remembered?

Jon Laerdal:

That's a big difficult question. I um professionally I like to be remembered as somebody who who uh was good to work with. And uh and uh helped enable uh, first of all, now towards 2030, a real impact on helping save lives, and beyond that to scale simulation and lifesaver's preparedness significantly better. I uh I think there's enormous potential. So I'd like to be remembered as somebody who helped drive that agenda. And uh personally, of course, as as a good listener and as a curious person and as a as a good dad and a pretty decent uh husband, I'd be good.

Deb Tauber:

Great, great. Now, if our listeners want to get a hold of the company, where should they go if they want to support some of these initiatives or learn more about them?

Jon Laerdal:

You can just go to Lairdel.com or you can Google uh WhatMeal Lives. And we're uh in more than 30 countries with colleagues and with our our offices, or you can just find me on LinkedIn or send me an email on john.laerdal at Laerdal.com. I'll do my best to uh to respond quickly to that. So yeah, we're totally approachable. So happy to uh to meet up with people.

Deb Tauber:

Yes, I've been inspired by your humbleness during this interview, and I thank You so much.

unknown:

Thank you.

Jon Laerdal:

Likewise, thanks again for the invitation.

Deb Tauber:

Yeah. Jared, do you have anything?

Jerrod Jeffries:

No, it's it's great to hear. You know, I think Lairdal is seen, you know, at these conferences, especially with most of our listeners being on the simulation side, but Lairdol's seen as you know the platinum premiere, whatever type of sponsor, uh, in these large halls around different different venues, and to see where you started versus you know the growth of the company and then also that of even where the future holds. I mean, Tanzania and in low resource settings, I don't want to say dominated, but they had a good share of our time here. And and I think that's you're looking forward, you're not just uh resting on your loins and saying, okay, well, we did this. Great job. It's more of I I think the innovativeness and what's next and how do you continue to support and help has been it's great to see. And I think that can be shared in the larger setting within this industry. And so thank you for your time. Likewise, it was a pleasure.

Deb Tauber:

Thank you and happy simulating.

Disclaimer/ SIM vs/ Intro:

Thanks to SimVS again for sponsoring this week's episode. To learn more about their new IV infusion pump simulators, check out www.simvs.com. Thanks for joining us here at the Sim Cafe. We hope you enjoyed. Visit us at www.innovative simsolutions.com. And be sure to hit that like and subscribe button so you never miss an episode. Innovative Sim Solutions is your one stop shop for your simulation needs. A turnkey solution.

Contributor

Jerrod Jefferies

Co-host